CRDF Operating Cash Flow Growth
Cardiff Oncology Inc · Operating Cash Flow Growth
CRDF Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported2.37%period ending
CRDF TTM Cash from Operations YoY % (114.84% → 2.37%)
Year-over-year change
High-resolution chart · PNG
CRDF operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 2.3683% | |
| 12.4687% | |
| -0.6102% | |
| -22.1554% | |
| -30.4965% | |
| -42.6422% | |
| -22.0352% | |
| -4.3062% | |
| 1.8398% | |
| 7.0183% | |
| 8.6724% | |
| -4.142% | |
| -9.6245% | |
| -17.6063% | |
| -46.7882% | |
| -53.1727% | |
| -58.2177% | |
| -45.5829% | |
| -41.2256% | |
| -43.5928% | |
| -33.2969% | |
| -41.7351% | |
| -22.966% | |
| -6.3514% | |
| -1.6857% | |
| 3.0762% | |
| -0.5177% | |
| -5.3075% | |
| 13.3306% | |
| 21.1528% | |
| 43.3058% | |
| 55.3864% | |
| 45.471% | |
| 47.1479% | |
| 24.9962% | |
| -0.3834% | |
| -9.1581% | |
| -35.308% | |
| -40.331% | |
| -50.4093% | |
| -54.332% | |
| -65.7517% | |
| -73.7908% | |
| -78.9683% | |
| -85.5725% | |
| -72.7483% | |
| -73.9368% | |
| -58.0891% | |
| -54.235% | |
| -49.9984% | |
| -48.2827% | |
| -63.7303% | |
| -95.7518% | |
| -149.6203% | |
| -155.642% | |
| -128.7517% | |
| -50.7098% | |
| 14.7412% | |
| 7.5524% | |
| -7.3381% | |
| 12.9166% | |
| 114.8447% |